Boothbay Fund Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Boothbay Fund Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,730	Closed	-$312K	–	2424
2021 Q3	$282K	Buy	+4,730	New	+$279K	0.01%	1364
2018 Q2	–	Sell	-5,093	Closed	-$201K	–	949
2018 Q1	$201K	Buy	+5,093	New	+$198K	0.02%	608

Boothbay Fund Management's ARNA Position: Q4 2021 in Review

Boothbay Fund Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 4,730 shares — an estimated $312K sold.

Boothbay Fund Management first reported a position in ARNA in Q1 2018 and held it in 2 quarters. The position peaked at $282K in Q3 2021. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

Boothbay Fund Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
Boothbay Fund Management sold 4,730 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $312K.
Boothbay Fund Management first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 2 quarters.
Boothbay Fund Management's Arena Pharmaceuticals Inc position peaked at $282K in Q3 2021.
316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.